Mesothelioma Rates Steady Despite Decline in Asbestos Use

By Peter DePaolis
Attorney

The use of asbestos in the U.S. has been reduced dramatically in recent decades, but mesothelioma cancer has remained steady. Working toward finding a cure or creating better treatment options for those diagnosed with mesothelioma has never been more important.

According to records from the National Cancer Institute, the annual rate of mesothelioma in the U.S. remains above the 3,000 mark, where it has stayed for 30 years.

Mesothelioma is a rare but aggressive cancer that is caused primarily by exposure to asbestos, a mineral that was used extensively for commercial purposes through much of the 20th century. The dangers of asbestos have been known since the 1930s, but its use continued to increase throughout the next 40 years.

The use of asbestos in America peaked in 1973, but has dropped steadily since, as the public demand for more restrictions became more apparent; however, mesothelioma rates never dropped. One of the main reasons is the latency period between initial exposure to asbestos fibers and a confirmed diagnosis, which can take anywhere from 10-50 years.

Have You Been Exposed to Asbestos?

If you think you may have been exposed to asbestos, or if you have received a mesothelioma diagnosis, contact our firm today at (202) 659-5500 for a free consultation, or visit our website to fill out our online form.

Koonz, McKenney, Johnson & DePaolis L.L.P.

Maryland, Washington, D.C., and Virginia Injury Attorneys

About the Author
Peter DePaolis joined the firm in 1980 and has since represented a large number of individuals involved in automobile collisions, truck accidents, bus crashes, defective products, and medical malpractice cases. A significant portion of Mr. DePaolis’ practice is devoted to working on behalf of people suffering from asbestosis, mesothelioma, and other asbestos-related cancers. He has led his firm’s fight against the asbestos industry and has recovered over $30 million in damages for asbestos victims and their families.